Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 51, 4665-4670, September 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kessel, D.
Right arrow Articles by Schulz, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kessel, D.
Right arrow Articles by Schulz, V.

Characterization of Multidrug Resistance by Fluorescent Dyes1

David Kessel2, William T. Beck, Debra Kukuruga and Veronique Schulz

Departments of Pharmacology [D. K., V. S.] and Pathology [D. Ku.], Wayne State University, Detroit, Michigan 48201, and Department of Pharmacology [W. B.], St. Jude Children's Hospital, Memphis, Tennessee 38101

Fluorimetric techniques were used to examine accumulation of fluorescent probes by the P388 murine leukemia and an anthracycline-resistant subline, P388/Adriamycin(ADR), which expresses the multidrug-resistant phenotype. P388 could be differentiated from P388/ADR on the basis of fluorescence intensity measurements using 3 classes of cationic dyes that are sensitive to membrane potential differences: rhodamine esters, cyanines, and styrylpyridinium dyes. But fluorescence intensity differences were also observed with potential-insensitive dyes: zwitterionic rhodamines and an acridine orange derivative. In all cases, fluorescence intensity differences were caused by impaired dye accumulation, and could be eliminated by treatment of P388/ADR cells with verapamil. Moreover, fluorescence signals from 2 anionic potential-sensitive dyes, merocyanine 540 and a bis-oxonol, were identical in P388 and P388/ADR. None of these dyes could be used to delineate CCRF-CEM, a lymphoblastic leukemia of human origin from the CEM/VM-1 subline that exhibits a markedly atypical drug resistance pattern not based on an enhanced outward transport. But accumulation of both neutral and cationic dyes was impaired in CEM/VLB100, a subline of CCRF-CEM expressing mdr. These studies show that many cationic and neutral fluorescent probes are substrates for the enhanced outward drug transport system associated with P388/ADR cells, and cannot be used to probe membrane-potential differences in cells expressing the mdr phenotype. With several dyes, differences in fluorescence intensity were sufficient so that flow cytometry could be used to delineate P388 from P388/ADR and CCRF-CEM from CEM-VLB100. The latter technique may be useful for identifying malignant cell populations expressing multidrug resistance in patients with neoplastic disease.

1 This work was supported in part by Grants CA 23378, CA 40570, and CA 21765 from the National Cancer Institute, NIH, Department of Health and Human Services, and by a grant from the American Lebanese Associated Charities.

2 To whom requests for reprints should be addressed.

Received 2/22/91. Accepted 6/12/91.




This article has been cited by other articles:


Home page
BloodHome page
D. Becton, G. V. Dahl, Y. Ravindranath, M. N. Chang, F. G. Behm, S. C. Raimondi, D. R. Head, K. C. Stine, N. J. Lacayo, B. I. Sikic, et al.
Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421
Blood, February 15, 2006; 107(4): 1315 - 1324.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. Crivellato, L. Candussio, A. M. Rosati, F. Bartoli-Klugmann, F. Mallardi, and G. Decorti
The Fluorescent Probe Bodipy-FL-Verapamil Is a Substrate for Both P-glycoprotein and Multidrug Resistance-related Protein (MRP)-1
J. Histochem. Cytochem., May 1, 2002; 50(5): 731 - 734.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Kim, J. M. Dintaman, D. S. Waddell, and J. A. Silverman
Saquinavir, an HIV Protease Inhibitor, Is Transported by P-Glycoprotein
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1439 - 1445.
[Abstract] [Full Text]


Home page
BloodHome page
M. Kim, D. D. Cooper, S. F. Hayes, and G. J. Spangrude
Rhodamine-123 Staining in Hematopoietic Stem Cells of Young Mice Indicates Mitochondrial Activation Rather Than Dye Efflux
Blood, June 1, 1998; 91(11): 4106 - 4117.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. A. Kunz-Schughart, R. C. Habbersett, and J. P. Freyer
Mitochondrial function in oncogene-transfected rat fibroblasts isolated from multicellular spheroids
Am J Physiol Cell Physiol, November 1, 1997; 273(5): C1487 - C1495.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kolaczkowski, M. van der Rest, A. Cybularz-Kolaczkowska, J.-P. Soumillion, W. N. Konings, and A. Goffeau
Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5p
J. Biol. Chem., December 6, 1996; 271(49): 31543 - 31548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1991 by the American Association for Cancer Research.